SpeeDx, MolGen to partner on COVID-19 test

LabPulse.com staff writers
Jul 5, 2021
2021 01 11 17 03 4617 Covid Diagnostic Test Kit 400

SpeeDx and MolGen plan to collaborate on the supply and distribution of a COVID-19 test across Europe and the Asia Pacific region.

Under the partnership, the two firms will integrate SpeeDx's CE-IVD SARS-CoV-2 assay using MolGen's PurePrep nucleic acid extraction equipment to provide specimen handling, test setup, and results reporting, the two firms said.

Latest in Agreement
Concentriq Dx 2 (002)
Agilent Technologies, Proscia ink digital pathology distribution agreement
March 8, 2023
Hands Shaking Deal Social
Exact Sciences executes private placement of convertible senior notes
February 23, 2023
Women Laboratory Social
Quest Diagnostics, New York-Presbyterian ink laboratory services agreement
February 14, 2023
Business Handshake Intelligence Social
S2 Genomics, Bonsailab ink Spain, Portugal distribution agreement
January 17, 2023
Related Stories
2021 01 11 17 03 4617 Covid Diagnostic Test Kit 400
PCR
SpeeDx receives clearance for COVID test
2019 06 11 20 36 8064 Neisseria Gonorrhoeae Gonorrhea 400
Clinical Trial
SpeeDx to break ground for new facility
2021 01 11 17 03 4617 Covid Diagnostic Test Kit 400
Home
Poor Blacks, affluent whites most likely to get COVID at pandemic's start
2021 04 27 23 07 7463 Sars Co V 2 Particles Sem Niaid 400
PCR
SpeeDx secures European CE-IVD Mark for COVID-19 test
More in Agreement
Agilent Technologies, Proscia ink digital pathology distribution agreement
Combining Agilent's pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality, Agilent said.
March 8, 2023
Concentriq Dx 2 (002)
Exact Sciences executes private placement of convertible senior notes
Under the agreement, Exact Sciences has agreed to issue to the holder $500 million aggregate principal amount of a new series of 2% convertible senior notes due in 2030.
February 23, 2023
Hands Shaking Deal Social
Quest Diagnostics, New York-Presbyterian ink laboratory services agreement
Their strategic objective is to broaden access to laboratory services for providers in New York, Connecticut, New Jersey, and beyond.
February 14, 2023
Women Laboratory Social
S2 Genomics, Bonsailab ink Spain, Portugal distribution agreement
S2 Genomics is partnering with Bonsailab to promote, sell, and support its Singulator 100 and 200 systems, which provide consistent isolation of single cells or nuclei from solid-tissue samples.
January 17, 2023
Business Handshake Intelligence Social
T2 Biosystems nabs contract extension with group purchasing organization
Products covered under the contract with Vizient, a purchasing organization for healthcare institutions, include the T2Dx Instrument, T2Bacteria Panel, and T2Candida Panel. All detect sepsis-causing bacterial and fungal pathogens from whole blood.
December 28, 2022
Hands Shaking Deal Social
Source LDPath, Ibex Medical Analytics ink agreement to deploy AI-enabled pathology platform
AI-enabled tools will be used to diagnose multiple tissue types and improve diagnostic accuracy and efficiency, Source LDPath said.
December 7, 2022
Pathology Digital Workstation Microscope Social
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
Quest Diagnostics offers suite of services for transplant patients and living donors
More in Agreement
Quest Diagnostics, Premier ink laboratory stewardship platform and services agreement
Premier members can obtain specific negotiated pricing and terms to access Quest's laboratory stewardship solution.
December 1, 2022
Lab Biochemical Analyzer Social
KSL Pulse Scientific to distribute Lucira Health COVID, flu molecular test in Canada
The test was approved by Health Canada and will be available to healthcare providers and consumers for the fall and winter COVID and flu season.
November 29, 2022
Influenza Virus Social
Bio-Rad Laboratories, NuProbe USA sign licensing agreement for digital PCR assays
The agreement allows NuProbe to license its allele enrichment technologies to Bio-Rad for the development of multiplexed digital PCR assays
November 8, 2022
Digital Science Lab Social
Sense Biodetection signs distribution agreement with Biotecom for MDx platform
The agreement allows Biotecom to provide Chilean hospitals, laboratories, and clinics with the Veros molecular testing platform.
November 2, 2022
Business Deal Corporate Social
QuantuMDx inks distribution agreement with Menarini
According to the agreement, Menarini will handle the distribution and marketing of the Q-POC platform, COVID assay, and QuantuMDx’s SARS-CoV-2/Flu A/B/RSV Respiratory Panel test in the U.K. and France.
November 2, 2022
Global Collaboration Business Social
Shineco moves into point-of-care testing, inks stock purchase agreement with Chinese biotech
The stock purchase agreement is an initiative in Shineco’s strategy aimed at moving into the point-of-care testing industry.
October 25, 2022
Business Handshake Man Social
Page 1 of 16
Next Page